MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

$FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma$

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Tetra Pharm Technologies advances CB1 antagonist, TPT0701, for appetite suppression into preclinical testing

Dipal Doshi has been elected to Azenta's Board of Directors

30 Jan 2025

Azenta, Inc. announced that Dipal Doshi, Chief Executive Officer of Entrada Therapeutics (NASDAQ:...

Molecular Residual Disease and Liquid Biopsy Solutions Launched by Labcorp

First National Campaign Launched by Trauma Intervention Programs (TIP)

PureTech Secures U.S. and EU Orphan Designations for Deupirfenidone (LYT-100) in IPF

$CellCentric Launches DOMMINO-1, a Phase 2 Trial of Inobrodib Combined with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma$

CellCentric Launches DOMMINO-1, a Phase 2 Trial of Inobrodib Combined with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Eli Lilly’s Foundayo™: The Newest GLP-1 Innovation Offered by Ro

By Ro
Ro
09 Apr 2026

Approval and Launch of Nintedanib Capsules

By Dexcel Pharma USA
Dexcel Pharma USA
09 Apr 2026

When Every Beat Matters, BD Helps Clinicians Gain Continuous, Noninvasive Blood Pressure Insight to Eliminate Blind Spots

By BD
BD
07 Apr 2026

Dr. Amit Singal Appointed as Chief Medical Officer by Curve Biosciences

By Curve Biosciences
Curve Biosciences
07 Apr 2026

MEDIPEEL Gains Momentum in the K-Pharmacy Channel in Korea.

By MEDIPEEL
MEDIPEEL
06 Apr 2026

Epia Neuro Launches Intent-Driven Neural Technology to Restore Function After Stroke and Address Cognitive Decline

By Epia Neuro
Epia Neuro
06 Apr 2026

The Digital Pharma Advances Conference 2026

Most Popular

To drive global expansion of digital chemistry and discovery, Chemify raises over $50 million in an oversubscribed Series B round

By Chemify

Oct 21
Orthofix Receives FDA 510(k) Clearance for Rodeo™ Telescopic Nail

By Orthofix Medical Inc.

May 09
Kedrion Selected by Biotest to Distribute FDA-Approved Immunoglobulin Yimmugo® in the U.S

By Kedrion Biopharma

Jul 01

April 2026

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Search your requirement

Social media

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Tetra Pharm Technologies advances CB1 antagonist, TPT0701, for appetite suppression into preclinical testing

Dipal Doshi has been elected to Azenta's Board of Directors

Molecular Residual Disease and Liquid Biopsy Solutions Launched by Labcorp

First National Campaign Launched by Trauma Intervention Programs (TIP)

PureTech Secures U.S. and EU Orphan Designations for Deupirfenidone (LYT-100) in IPF

CellCentric Launches DOMMINO-1, a Phase 2 Trial of Inobrodib Combined with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Eli Lilly’s Foundayo™: The Newest GLP-1 Innovation Offered by Ro

Approval and Launch of Nintedanib Capsules

When Every Beat Matters, BD Helps Clinicians Gain Continuous, Noninvasive Blood Pressure Insight to Eliminate Blind Spots

Dr. Amit Singal Appointed as Chief Medical Officer by Curve Biosciences

MEDIPEEL Gains Momentum in the K-Pharmacy Channel in Korea.

Epia Neuro Launches Intent-Driven Neural Technology to Restore Function After Stroke and Address Cognitive Decline

Most Popular

To drive global expansion of digital chemistry and discovery, Chemify raises over $50 million in an oversubscribed Series B round

Orthofix Receives FDA 510(k) Clearance for Rodeo™ Telescopic Nail

Kedrion Selected by Biotest to Distribute FDA-Approved Immunoglobulin Yimmugo® in the U.S

User Area

Discover

Engage with Us

Search your requirement

Social media

Featured Press Releases

Most Popular

User Area

Discover

Engage with Us

Subscribe for e-Newsletter Monthly